![Li Chun Han](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Li Chun Han
Direttore/Membro del Consiglio presso MICROBIO CO., LTD.
Posizioni attive di Li Chun Han
Società | Posizione | Inizio | Fine |
---|---|---|---|
MICROBIO CO., LTD. | Direttore/Membro del Consiglio | 06/06/2012 | - |
Independent Dir/Board Member | 06/06/2012 | - | |
SINEW PHARMA INC. | Direttore/Membro del Consiglio | 27/06/2019 | - |
Independent Dir/Board Member | 27/06/2019 | - | |
StemCyte, Inc.
![]() StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Direttore/Membro del Consiglio | 24/04/2014 | - |
Independent Dir/Board Member | 24/04/2014 | - | |
Stemcyte Taiwan
![]() Stemcyte Taiwan Medical/Nursing ServicesHealth Services Stemcyte Taiwan, founded in 2000, is a private company based in New Taipei City, Taiwan that specializes in umbilical cord blood banking. Stemcyte Taiwan has been recognized by over 350 medical centers worldwide and has helped with over 2,500 cord blood transplants. The Taiwanese company has a large public cord blood bank and exclusive patent technology for red blood cell separation. Stemcyte Taiwan has received international accreditations from AABB, FACT, NMDP, WMDA, and FDA, providing customers with secure and transparent contracts. | Direttore/Membro del Consiglio | - | - |
Independent Dir/Board Member | - | - |
Storia della carriera di Li Chun Han
Precedenti posizioni note di Li Chun Han
Società | Posizione | Inizio | Fine |
---|---|---|---|
President Futures Corp.
![]() President Futures Corp. Investment Banks/BrokersFinance Part of Uni-President Enterprises Corp., President Futures Corp. is a financial company based in Taipei, Taiwan. The Taiwanese company specializes in providing investors with a tool to hedge against interest rate risks and to capitalize on potential profits from interest rate changes through the use of financial derivatives, specifically the US Treasury bond futures. The company offers a comprehensive guide on the basic concepts, operational principles, and factors affecting the price of US Treasury bond futures. The guide also includes information on the types of US Treasury bonds, the contract specifications of US Treasury bond futures, and how to calculate profits and losses. The company's services are mainly targeted towards institutional investors who hold large amounts of bonds and require flexible trading options. | Presidente | - | - |
PRESIDENT SECURITIES CORPORATION | Corporate Officer/Principal | - | - |
Formazione di Li Chun Han
National Chung Hsing University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Taiwan | 7 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 4 |
Independent Dir/Board Member | 4 |
Undergraduate Degree | 1 |
Settori
Health Technology | 4 |
Finance | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
MICROBIO CO., LTD. | Health Technology |
SINEW PHARMA INC. | Health Technology |
PRESIDENT SECURITIES CORPORATION | Finance |
Aziende private | 3 |
---|---|
StemCyte, Inc.
![]() StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Health Technology |
President Futures Corp.
![]() President Futures Corp. Investment Banks/BrokersFinance Part of Uni-President Enterprises Corp., President Futures Corp. is a financial company based in Taipei, Taiwan. The Taiwanese company specializes in providing investors with a tool to hedge against interest rate risks and to capitalize on potential profits from interest rate changes through the use of financial derivatives, specifically the US Treasury bond futures. The company offers a comprehensive guide on the basic concepts, operational principles, and factors affecting the price of US Treasury bond futures. The guide also includes information on the types of US Treasury bonds, the contract specifications of US Treasury bond futures, and how to calculate profits and losses. The company's services are mainly targeted towards institutional investors who hold large amounts of bonds and require flexible trading options. | Finance |
Stemcyte Taiwan
![]() Stemcyte Taiwan Medical/Nursing ServicesHealth Services Stemcyte Taiwan, founded in 2000, is a private company based in New Taipei City, Taiwan that specializes in umbilical cord blood banking. Stemcyte Taiwan has been recognized by over 350 medical centers worldwide and has helped with over 2,500 cord blood transplants. The Taiwanese company has a large public cord blood bank and exclusive patent technology for red blood cell separation. Stemcyte Taiwan has received international accreditations from AABB, FACT, NMDP, WMDA, and FDA, providing customers with secure and transparent contracts. | Health Services |
- Borsa valori
- Insiders
- Li Chun Han
- Esperienza